Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Foy

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
The British Journal of Surgery|June 2, 2007
Comparison of different methods of risk stratification in urgent and emergency surgeryW D Neary, D Prytherch, C Foy, et al.
Clinical Neurology and Neurosurgery|November 29, 2019
Cerebrospinal fluid opening pressure: The effect of body mass index and body compositionB R Wakerley, R Warner, M Cole, et al.
Thorax|January 30, 2003
Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trialM Thomas, R K McKinley, E Freeman, et al.
Lancet (London, England)|September 18, 1999
Residential proximity to industry and adverse birth outcomesR S Bhopal, J A Tate, C Foy, et al.
The Journal of Biological Chemistry|February 18, 2011
Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivoKevin C Foy, Zhenzhen Liu, Gary Phillips, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|June 13, 2006
Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgeryW D Neary, A McCrirrick, C Foy, et al.
The Journal of Laryngology and Otology|June 30, 2007
Endoscopic endonasal laser versus endonasal surgical dacryocystorhinostomy for epiphora due to nasolacrimal duct obstruction: prospective, randomised, controlled trialS Maini, N Raghava, R Youngs, et al.
Oncoimmunology|May 6, 2015
HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cellsMegan Jo Miller, Kevin C Foy, Jay P Overholser, et al.
Environmental Health Perspectives|June 13, 1998
Lung cancer, proximity to industry, and poverty in northeast EnglandT Pless-Mulloli, P Phillimore, S Moffatt, et al.
Oncoimmunology|November 22, 2012
Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivoKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
The British Journal of Surgery|June 2, 2007
Comparison of different methods of risk stratification in urgent and emergency surgeryW D Neary, D Prytherch, C Foy, et al.
Clinical Neurology and Neurosurgery|November 29, 2019
Cerebrospinal fluid opening pressure: The effect of body mass index and body compositionB R Wakerley, R Warner, M Cole, et al.
Thorax|January 30, 2003
Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trialM Thomas, R K McKinley, E Freeman, et al.
Lancet (London, England)|September 18, 1999
Residential proximity to industry and adverse birth outcomesR S Bhopal, J A Tate, C Foy, et al.
The Journal of Biological Chemistry|February 18, 2011
Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivoKevin C Foy, Zhenzhen Liu, Gary Phillips, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|June 13, 2006
Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgeryW D Neary, A McCrirrick, C Foy, et al.
The Journal of Laryngology and Otology|June 30, 2007
Endoscopic endonasal laser versus endonasal surgical dacryocystorhinostomy for epiphora due to nasolacrimal duct obstruction: prospective, randomised, controlled trialS Maini, N Raghava, R Youngs, et al.
Oncoimmunology|May 6, 2015
HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cellsMegan Jo Miller, Kevin C Foy, Jay P Overholser, et al.
Environmental Health Perspectives|June 13, 1998
Lung cancer, proximity to industry, and poverty in northeast EnglandT Pless-Mulloli, P Phillimore, S Moffatt, et al.
Oncoimmunology|November 22, 2012
Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivoKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Pageof 8